Viewing nowCrelorba Tablet 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

MFDS item code 201405754 · Approved 2014.12.04 · Insurance code 643703960
Treatment for hypercholesterolemia and reduction of cardiovascular disease risk
This medication is primarily used as an adjunct to diet and exercise when needed for patients with primary hypercholesterolemia and mixed hyperlipidemia. It is also helpful in the treatment of patients with homozygous familial hypercholesterolemia and effectively lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It is also utilized as an adjunct to diet in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia who meet certain criteria. It is also applied for the treatment of patients with primary dysbetalipoproteinemia and contributes to reducing cardiovascular disease risk. Specifically, it is effective in lowering the risk of stroke, myocardial infarction, and arterial revascularization. Overall, it is used to improve these factors and promote cardiovascular health.
Starting at a dose of 5 mg once daily at any time of the day, regardless of food. If necessary, the dose may be increased to 10 mg once daily at intervals of 4 weeks or longer, based on LDL cholesterol levels and treatment targets, and may be titrated up to a maximum of 20 mg once daily.
For pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia, a dose of 5 mg to 20 mg is administered once daily. The dosage should be adjusted according to the individual treatment goals at intervals of 4 weeks or longer.
This medication should not be used by individuals who are allergic to certain components. People with active liver disease or unexplained elevated liver enzyme levels should also avoid this medication. Patients with muscle disease or those taking cyclosporine, as well as individuals with severely impaired kidney function, should avoid this medication. Women who are pregnant or breastfeeding and those of childbearing age who are not using adequate contraception should refrain from using this medication. Those at high risk for myopathy or rhabdomyolysis should particularly avoid high doses (40 mg), especially if they have impaired kidney function, hypothyroidism, or family history. This medication contains lactose, thus should not be taken by individuals with lactose intolerance or related genetic disorders. Those who consume alcohol excessively or have a history of liver disease should have regular liver function tests while on this medication. If symptoms such as muscle pain or weakness occur, notify your healthcare provider immediately, and consider discontinuing use as necessary. In cases of acute severe conditions or severe renal failure, discontinue this medication immediately. Rarely, this medication may lead to severe muscle weakness or ocular myasthenia, and it should be halted immediately if symptoms occur. When combined with other specific medications, the risk of muscle-related side effects may increase, so consult with your healthcare provider regarding concomitant medications. High-dose use may lead to temporary proteinuria, which may require kidney function tests. In Asians, the drug concentration may be higher, necessitating dosage adjustments. In children and adolescents, the effects on growth and secondary sexual characteristics should be considered when deciding on use. Adverse reactions such as interstitial lung disease, severe liver damage, and severe skin reactions have been reported rarely; discontinue if unusual symptoms occur and consult a healthcare provider. This medication can interact with certain drugs, so if you are taking other medications, be sure to inform your healthcare provider and exercise caution. Women who are pregnant or planning to become pregnant should avoid this medication and use suitable contraceptive methods. In cases of overdose, there is no specific antidote, and treatment and liver and muscle function tests should be conducted based on symptoms. Caution should be exercised when driving or operating machinery as dizziness may occur. Although no specific cancer risk has been reported with long-term use of this medication, ongoing observation for adverse reactions during treatment is necessary.
Allergic reactions including urticaria and angioedema, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, fatal and non-fatal liver failure, jaundice, hepatitis, severe myasthenia, ocular myasthenia, rhabdomyolysis, immune-mediated necrotizing myopathy, polyneuropathy, peripheral neuropathy, thrombocytopenia, edema, severe allergic reactions, severe skin reactions, respiratory distress, difficulty breathing
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. By doing so, the effectiveness of the medication can be maintained for an extended period.
Pink circular film-coated tablet
30 tablets (10 tablets/PTP) x 3
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.